Fatima Mora-Valdes
Sydney, NSW 2031, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma.
Journal: Science translational medicine
Published: January 14, 2026
Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications.
Journal: International journal of molecular sciences
Published: June 03, 2025
The Bermuda Triangle of paediatric brain cancers: epigenetics, developmental timing window and cell of origin.
Journal: Cancer metastasis reviews
Published: May 22, 2025
Modelling the metastatic immune microenvironment in triple-negative breast cancer.
Journal: Breast cancer research : BCR
Published: April 11, 2025
EZHIP's role in diffuse midline glioma: echoes of oncohistones?
Journal: Trends in cancer
Published: April 27, 2024
Performance comparison of high throughput single-cell RNA-Seq platforms in complex tissues.
Journal: Heliyon
Published: April 01, 2024
Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologies.
Journal: Frontiers in cell and developmental biology
Published: May 08, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
Journal: Cancer research
Published: March 22, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.
Journal: Cancer research
Published: March 22, 2023
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
Journal: The Journal of clinical investigation
Published: March 08, 2023
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Journal: The Journal of clinical investigation
Published: September 28, 2022
Last Updated: 09/26/2026